RasGRP1 induces autophagy and transformation-associated changes in primary human keratinocytes.
Journal
Translational oncology
ISSN: 1936-5233
Titre abrégé: Transl Oncol
Pays: United States
ID NLM: 101472619
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
26
05
2020
revised:
21
08
2020
accepted:
21
09
2020
pubmed:
20
10
2020
medline:
20
10
2020
entrez:
19
10
2020
Statut:
ppublish
Résumé
Ras mutations are present in only a subset of sporadic human cutaneous squamous cell carcinomas (cSCC) even though Ras is activated in most. This suggests that other mechanisms of Ras activation play a role in the disease. The aberrant expression of RasGRP1, a guanyl nucleotide exchange factor for Ras, is critical for mouse cSCC development through its ability to increase Ras activity. However, the role of RasGRP1 in human keratinocyte carcinogenesis remains unknown. Here we report that RasGRP1 is significantly elevated in human cSCC and that high RasGRP1 expression in human primary keratinocytes triggered activation of endogenous Ras and significant morphological changes including cytoplasmic vacuole formation and growth arrest. Moreover, RasGRP1-expressing cells were autophagic as indicated by LC3-II increase and the formation of LC3 punctae. In an in vitro organotypic skin model, wild type keratinocytes generated a well-stratified epithelium, while RasGRP1-expressing cells failed to do so. Finally, RasGRP1 induced transformation-like changes in skin cells from Li-Fraumeni patients with inactivating p53 mutations, demonstrating the oncogenic potential of this protein. These results support a role for RasGRP1 in human epidermal keratinocyte carcinogenesis and might serve as an important new therapeutic target.
Identifiants
pubmed: 33074128
pii: S1936-5233(20)30372-7
doi: 10.1016/j.tranon.2020.100880
pmc: PMC7569238
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100880Subventions
Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA096841
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA165128
Pays : United States
Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Arch Dermatol. 1995 Jul;131(7):796-800
pubmed: 7611795
N Engl J Med. 2001 Mar 29;344(13):975-83
pubmed: 11274625
Cancer Biol Ther. 2002 Nov-Dec;1(6):599-606
pubmed: 12642680
J Biol Chem. 2006 Nov 24;281(47):36132-9
pubmed: 17012239
Cancer Res. 1989 Sep 1;49(17):4682-9
pubmed: 2547513
Cell. 1986 Aug 1;46(3):447-56
pubmed: 3015415
Nature. 2009 Sep 17;461(7262):411-4
pubmed: 19727076
Nat Cell Biol. 2015 Jun;17(6):804-15
pubmed: 26005835
Oncotarget. 2014 Feb 15;5(3):577-86
pubmed: 24583697
Cancer Res. 2007 Nov 1;67(21):10190-7
pubmed: 17974959
Carcinogenesis. 2009 Nov;30(11):1880-8
pubmed: 19783847
Mol Cell Biol. 2000 Feb;20(4):1436-47
pubmed: 10648628
Oncogene. 2003 Sep 4;22(38):5958-66
pubmed: 12955074
Nat Protoc. 2007;2(1):178-86
pubmed: 17401352
Nature. 2003 Feb 6;421(6923):639-43
pubmed: 12571598
Cell. 1997 Mar 7;88(5):593-602
pubmed: 9054499
Nature. 1986 Oct 30-Nov 5;323(6091):822-4
pubmed: 2430189
Nature. 2004 Nov 18;432(7015):307-15
pubmed: 15549092
Lancet. 2010 Feb 20;375(9715):673-85
pubmed: 20171403
Mol Biol Cell. 2000 Oct;11(10):3453-67
pubmed: 11029048
Mol Carcinog. 1995 Apr;12(4):225-35
pubmed: 7727044
Mol Cell Biol. 1998 Dec;18(12):6995-7008
pubmed: 9819387
Anticancer Res. 2005 Mar-Apr;25(2B):1205-10
pubmed: 15865067
Exp Dermatol. 2010 Feb;19(2):151-3
pubmed: 20156290
BMC Med Genomics. 2008 Apr 28;1:13
pubmed: 18442402
Mol Carcinog. 1991;4(3):196-202
pubmed: 2064725
Oncogene. 2005 Apr 14;24(16):2695-704
pubmed: 15829980
Carcinogenesis. 2014 May;35(5):1084-91
pubmed: 24464785
Dermatology. 2001;202(3):203-6
pubmed: 11385224
Blood. 2000 May 15;95(10):3199-203
pubmed: 10807788
Mol Carcinog. 1998 Jun;22(2):73-83
pubmed: 9655251
Cancer Res. 2007 Jan 1;67(1):276-80
pubmed: 17210708
Cell. 2010 Feb 5;140(3):313-26
pubmed: 20144757
Am J Pathol. 2009 Jul;175(1):392-9
pubmed: 19497993
J Biol Chem. 2010 May 21;285(21):15724-30
pubmed: 20308057
Autophagy. 2007 May-Jun;3(3):181-206
pubmed: 17224625
J Virol. 2003 Feb;77(3):2056-62
pubmed: 12525640
Nature. 2013 May 30;497(7451):633-7
pubmed: 23665962
Cell. 2007 Jun 1;129(5):865-77
pubmed: 17540168
Nat Commun. 2012;3:1168
pubmed: 23132018
Mol Cell. 2011 Apr 8;42(1):23-35
pubmed: 21353614
Science. 1998 May 15;280(5366):1082-6
pubmed: 9582122
Hum Pathol. 2008 Mar;39(3):344-9
pubmed: 18045646
Toxicol Appl Pharmacol. 2007 Nov 1;224(3):241-8
pubmed: 17270229
Nat Genet. 2002 Sep;32(1):166-74
pubmed: 12185365
Autophagy. 2005 Jul;1(2):84-91
pubmed: 16874052
J Virol. 2008 Sep;82(17):8820-7
pubmed: 18579583
J Biol Chem. 2003 Dec 26;278(52):52792-801
pubmed: 14532295
Cell. 1994 Sep 23;78(6):949-61
pubmed: 7923364